The Nigeria Center for Disease Control has confirmed the death of two, and infection of five people from Lassa fever in Edo, Ebonyi and Ondo states, including a health worker.
In addition to an Ebola vaccine, the Coalition for Epidemic Preparedness Innovations is currently funding the development of vaccines for Lassa fever, Middle East respiratory syndrome, Nipah virus, and coronavirus at the Jenner Institute; and by using the same technology as the Ebola vaccine — called viral vectors — researchers can significantly reduce the time it takes to develop vaccines.
The Nigeria Centre for Disease Control (NCDC) has confirmed three new cases of Lassa fever in Ondo State, including a health worker with two new deaths.
Analysis calms fears that the virus had mutated into a super-bug that could move more easily from person to person.
A new vaccine against both rabies and Lassa has demonstrated effective protection in animal models of disease, the research also points to a new way to test for protection against the Lassa fever virus, a finding that could significantly speed vaccine development.
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced a collaboration to advance the development and manufacture of a vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) along with preclinical development of novel vaccines against Lassa and Nipah viruses.
Scientists hope that a new approach to vaccine development, combined with improved surveillance of potential future threats of outbreak, could help to massively reduce the impact of deadly diseases such as Ebola, Marburg and Lassa fever.
According to terms of the agreement, Profectus will receive $4.3 million from the Coalition for Epidemic Preparedness Innovations (CEPI) to support the first phase of its Lassa vaccine project, with an option to invest up to a total of $36 million over five years, which could cover procuring vaccine for stockpiling.
The Nigeria Centre for Disease Control (NCDC) has confirmed nine new cases of Lassa fever with two deaths, in one week, including the first confirmed case in Enugu State.
The International AIDS Vaccine Initiative (IAVI) has entered into a license agreement with the Public Health Agency of Canada (PHAC) toward advancing development, regulatory approval, and supply of a new vaccine candidate against Lassa fever virus